(0.29%) 5 106.25 points
(0.63%) 38 622 points
(0.62%) 17 759 points
(0.32%) $79.20
(-0.79%) $2.02
(0.30%) $2 316.50
(0.56%) $26.98
(0.53%) $967.70
(-0.09%) $0.931
(-0.15%) $10.98
(-0.16%) $0.797
(0.95%) $92.00
1.17% € 3.45
Live Chart Being Loaded With Signals
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally...
Stats | |
---|---|
Volumen de hoy | 289 074 |
Volumen promedio | 201 847 |
Capitalización de mercado | 1.07B |
EPS | €0 ( 2024-04-26 ) |
Próxima fecha de ganancias | ( €0 ) 2024-07-26 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | 12.30 |
ATR14 | €0.00700 (0.20%) |
Volumen Correlación
Faes Farma, S.A. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Faes Farma, S.A. Correlación - Moneda/Commodity
Faes Farma, S.A. Finanzas
Annual | 2023 |
Ingresos: | €451.17M |
Beneficio Bruto: | €297.12M (65.86 %) |
EPS: | €0.300 |
FY | 2023 |
Ingresos: | €451.17M |
Beneficio Bruto: | €297.12M (65.86 %) |
EPS: | €0.300 |
FY | 2022 |
Ingresos: | €438.75M |
Beneficio Bruto: | €282.02M (64.28 %) |
EPS: | €0.290 |
FY | 2021 |
Ingresos: | €398.56M |
Beneficio Bruto: | €252.40M (63.33 %) |
EPS: | €0.285 |
Financial Reports:
No articles found.
Faes Farma, S.A.
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico